Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 2, 2009

View Archived Issues

In vivo profile of K-056, a new adenosine A2A antagonist

12-month COMET-1 results show efficacy of CRx-102 in knee osteoarthritis

ADL-5510 reduces levodopa-induced dyskinesia in macaque model of PD

CP-8947, a novel nonsteroidal SPRM, exhibits progestational activity in preclinical study

New antiproliferative compounds disclosed by the European Molecular Biology Laboratory

Abeta production inhibitors claimed by Eisai for the treatment of Alzheimer's disease

Advaxis receives IRB approval for ADXS-11-001 trial in cervical dysplasia

ARYx Therapeutics prepares to outlicense budiodarone, ATI-7505 and tecarfarin

MAP Pharmaceuticals completes interim safety review of phase III Levadex trial

FDA grants emergency use authorization to Gen-Probe's Prodesse ProFlu-ST test for H1N1 flu

Pharmaxis files MAA with EMEA for Bronchitol in cystic fibrosis

FDA issues complete response letter regarding Transcept's NDA for Intermezzo

NasVax reports results from preclinical testing of H1N1 antigen formulated with VaxiSome

Ipsen launches Dysport in U.S. for treatment of cervical dystonia in adults

Eisai and Quintiles sign strategic collaboration agreement to develop six oncology drugs

Health Canada grants product approval for Intercell's Japanese encephalitis vaccine Ixiaro

Novartis Pharma decides not to license Idenix's IDX-184 for hepatitis C

Phase III trial evaluates effects of tolvaptan on kidney volume change in ADPKD

Everolimus/EC-MPS improves renal function in de novo renal transplant patients

Human data available for anti-obesity drug PSN-602

TVPR1 antagonists described by sanofi-aventis as analgesics

Genta reports results from phase III AGENDA trial of Genasense in advanced melanoma

Shire reports results from study of selective alpha-2A agonist Intuniv for ADHD

Celldex Therapeutics reports results from phase I studies of CDX-1307 in advanced epithelial cancers

Hutchison MediPharma starts phase I trial of HMPL-011 for auto-immune disease

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...